Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:48 UTC |
---|
HMDB ID | HMDB0014949 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Ribavirin |
---|
Description | Ribavirin is only found in individuals that have used or taken this drug. It is a nucleoside antimetabolite antiviral agent that blocks nucleic acid synthesis and is used against both RNA and DNA viruses. [PubChem]Ribavirin is readily phosphorylated intracellularly by adenosine kinase to ribavirin mono-, di-, and triphosphate metabolites. Ribavirin triphosphate (RTP) is a potent competitive inhibitor of inosine monophosphate (IMP) dehydrogenase, viral RNA polymerase and messenger RNA (mRNA) guanylyltransferase (viral) and can be incorporated into RNA in RNA viral species. Guanylyltranserase inhibition stops the capping of mRNA. These diverse effects result in a marked reduction of intracellular guanosine triphosphate (GTP) pools and inhibition of viral RNA and protein synthesis. Ribavirin is also incorporated into the viral genome causing lethal mutagenesis and a subsequent decrease in specific viral infectivity. |
---|
Structure | NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1 |
---|
Synonyms | Value | Source |
---|
1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide | ChEBI | 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide | ChEBI | RBV | ChEBI | Ribavirina | ChEBI | Ribavirine | ChEBI | Ribavirinum | ChEBI | Copegus | Kegg | Rebetol | Kegg | Ribasphere | Kegg | Virazole | Kegg | 1-b-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide | Generator | 1-Β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide | Generator | 1-b-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide | Generator | 1-Β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide | Generator | Vilona | HMDB | ICN brand OF ribavirin | HMDB | Ribamide | HMDB | Ribamidyl | HMDB | Ribavirin merck brand | HMDB | Virazide | HMDB | Grossman brand OF ribavirin | HMDB | Merck brand OF ribavirin | HMDB | Pfizer brand OF ribavirin | HMDB | Ribovirin | HMDB | Three rivers pharmaceuticals brand OF ribavirin | HMDB | Dermatech brand OF ribavirin | HMDB | Essex brand OF ribavirin | HMDB | Ribamidil | HMDB | Tribavirin | HMDB | Viramide | HMDB |
|
---|
Chemical Formula | C8H12N4O5 |
---|
Average Molecular Weight | 244.2047 |
---|
Monoisotopic Molecular Weight | 244.080769514 |
---|
IUPAC Name | 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide |
---|
Traditional Name | ribavirin |
---|
CAS Registry Number | 36791-04-5 |
---|
SMILES | NC(=O)C1=NN(C=N1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O |
---|
InChI Identifier | InChI=1S/C8H12N4O5/c9-6(16)7-10-2-12(11-7)8-5(15)4(14)3(1-13)17-8/h2-5,8,13-15H,1H2,(H2,9,16)/t3-,4-,5-,8-/m1/s1 |
---|
InChI Key | IWUCXVSUMQZMFG-AFCXAGJDSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as triazole ribonucleosides and ribonucleotides. These are nucleoside derivatives containing a ribose (or deoxyribose) moiety which is N-glycosylated to a triazole. Nucleotides have a phosphate group linked to the C5 carbon of the ribose (or deoxyribose) moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Nucleosides, nucleotides, and analogues |
---|
Class | Triazole ribonucleosides and ribonucleotides |
---|
Sub Class | Not Available |
---|
Direct Parent | Triazole ribonucleosides and ribonucleotides |
---|
Alternative Parents | |
---|
Substituents | - N-ribosyl-1,2,4-triazole
- Glycosyl compound
- N-glycosyl compound
- Pentose monosaccharide
- 2-heteroaryl carboxamide
- Monosaccharide
- Azole
- Tetrahydrofuran
- Triazole
- 1,2,4-triazole
- Heteroaromatic compound
- Carboxamide group
- Secondary alcohol
- Primary carboxylic acid amide
- Carboxylic acid derivative
- Oxacycle
- Azacycle
- Organoheterocyclic compound
- Alcohol
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Primary alcohol
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 174 - 176 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 33.2 g/L | Not Available | LogP | -2.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Ribavirin,1TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O)[C@@H]1O | 2432.9 | Semi standard non polar | 33892256 | Ribavirin,1TMS,isomer #2 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(N)=O)=N2)[C@@H]1O | 2392.7 | Semi standard non polar | 33892256 | Ribavirin,1TMS,isomer #3 | C[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC(C(N)=O)=N1 | 2404.5 | Semi standard non polar | 33892256 | Ribavirin,1TMS,isomer #4 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=N1 | 2445.3 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O | 2394.2 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C | 2394.1 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #3 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O)C=N1 | 2436.3 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(N)=O)=N2)[C@@H]1O[Si](C)(C)C | 2356.1 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #5 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O)C=N1 | 2426.9 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #6 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C)C=N1 | 2422.7 | Semi standard non polar | 33892256 | Ribavirin,2TMS,isomer #7 | C[Si](C)(C)N(C(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=N1)[Si](C)(C)C | 2485.9 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2348.5 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #2 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C)C=N1 | 2414.4 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #3 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O)C=N1 | 2408.1 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #4 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O)[C@@H]1O | 2466.3 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #5 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=N1 | 2393.5 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #6 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@@H]1O | 2457.0 | Semi standard non polar | 33892256 | Ribavirin,3TMS,isomer #7 | C[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N1 | 2450.6 | Semi standard non polar | 33892256 | Ribavirin,4TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=N1 | 2414.5 | Semi standard non polar | 33892256 | Ribavirin,4TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=N1 | 2390.2 | Standard non polar | 33892256 | Ribavirin,4TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C)[C@@H](O[Si](C)(C)C)[C@H]2O[Si](C)(C)C)C=N1 | 3677.5 | Standard polar | 33892256 | Ribavirin,4TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O | 2473.9 | Semi standard non polar | 33892256 | Ribavirin,4TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O | 2518.5 | Standard non polar | 33892256 | Ribavirin,4TMS,isomer #2 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O | 3227.9 | Standard polar | 33892256 | Ribavirin,4TMS,isomer #3 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C | 2457.0 | Semi standard non polar | 33892256 | Ribavirin,4TMS,isomer #3 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C | 2497.9 | Standard non polar | 33892256 | Ribavirin,4TMS,isomer #3 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C | 3153.1 | Standard polar | 33892256 | Ribavirin,4TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@@H]1O[Si](C)(C)C | 2451.6 | Semi standard non polar | 33892256 | Ribavirin,4TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@@H]1O[Si](C)(C)C | 2511.5 | Standard non polar | 33892256 | Ribavirin,4TMS,isomer #4 | C[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@@H]1O[Si](C)(C)C | 3159.8 | Standard polar | 33892256 | Ribavirin,5TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2492.9 | Semi standard non polar | 33892256 | Ribavirin,5TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2487.5 | Standard non polar | 33892256 | Ribavirin,5TMS,isomer #1 | C[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C)[Si](C)(C)C)=N2)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2988.5 | Standard polar | 33892256 | Ribavirin,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O)[C@@H]1O | 2695.5 | Semi standard non polar | 33892256 | Ribavirin,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(N)=O)=N2)[C@@H]1O | 2657.3 | Semi standard non polar | 33892256 | Ribavirin,1TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC(C(N)=O)=N1 | 2674.6 | Semi standard non polar | 33892256 | Ribavirin,1TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=N1 | 2680.6 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2884.4 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2872.7 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O)C=N1 | 2912.0 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(N)=O)=N2)[C@@H]1O[Si](C)(C)C(C)(C)C | 2829.5 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=N1 | 2895.9 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 2886.8 | Semi standard non polar | 33892256 | Ribavirin,2TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)N(C(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)C=N1)[Si](C)(C)C(C)(C)C | 2946.2 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(N)=O)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3025.6 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 3106.2 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O)C=N1 | 3104.2 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O)[C@@H]1O | 3114.1 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #5 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 3075.3 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #6 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@@H]1O | 3108.8 | Semi standard non polar | 33892256 | Ribavirin,3TBDMS,isomer #7 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N1 | 3107.3 | Semi standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 3260.4 | Semi standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 3107.1 | Standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=NN([C@@H]2O[C@H](CO[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)[C@H]2O[Si](C)(C)C(C)(C)C)C=N1 | 3839.6 | Standard polar | 33892256 | Ribavirin,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 3280.6 | Semi standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 3247.9 | Standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 3461.0 | Standard polar | 33892256 | Ribavirin,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 3273.3 | Semi standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 3238.2 | Standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 3416.8 | Standard polar | 33892256 | Ribavirin,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@@H]1O[Si](C)(C)C(C)(C)C | 3259.0 | Semi standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@@H]1O[Si](C)(C)C(C)(C)C | 3252.5 | Standard non polar | 33892256 | Ribavirin,4TBDMS,isomer #4 | CC(C)(C)[Si](C)(C)O[C@@H]1[C@@H](CO)O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@@H]1O[Si](C)(C)C(C)(C)C | 3410.2 | Standard polar | 33892256 | Ribavirin,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3407.2 | Semi standard non polar | 33892256 | Ribavirin,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3352.9 | Standard non polar | 33892256 | Ribavirin,5TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC[C@H]1O[C@@H](N2C=NC(C(=O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)=N2)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 3356.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Ribavirin GC-MS (Non-derivatized) - 70eV, Positive | splash10-08nc-9320000000-385cc2e08cf140e0ecee | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ribavirin GC-MS (3 TMS) - 70eV, Positive | splash10-0zpj-6922200000-75bb1d484addd27068ee | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Ribavirin GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-03di-0900000000-92e2bd11ded2c95f3fbd | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-03di-0900000000-109ebb69f722bb3a92d7 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-03di-2900000000-c0d63d0633c304d466ca | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-03xr-5900000000-c6f13aea6e263f2557f4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-02t9-9500000000-cefa4afc53cf92b724c3 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , negative-QTOF | splash10-014i-9200000000-3a87882b304f3a9c9995 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , positive-QTOF | splash10-03di-0900000000-d5e98a470d0e674937d2 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , positive-QTOF | splash10-03di-0900000000-c659efd26af31b3b98dc | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , positive-QTOF | splash10-03di-1900000000-56c00c62af197ae8eecb | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , positive-QTOF | splash10-03di-2900000000-aa387f940aedc4b69874 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin LC-ESI-QFT , positive-QTOF | splash10-03di-3900000000-795b88d3d651082dccb4 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 75V, Negative-QTOF | splash10-02t9-9500000000-2ad23cf2e8f500d101cc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 40V, Negative-QTOF | splash10-014l-9000000000-6a9ceaf94e48a5856e63 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 10V, Negative-QTOF | splash10-03di-0900000000-18802a19d16454483630 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 90V, Negative-QTOF | splash10-014i-9200000000-f26697f5224329016008 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 20V, Negative-QTOF | splash10-03di-3900000000-03e82b27fd25878e95dc | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 10V, Negative-QTOF | splash10-03di-0900000000-85ef00069e1dea09445a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 20V, Negative-QTOF | splash10-03di-3900000000-ec554c2067df2f7a90a5 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Ribavirin 40V, Negative-QTOF | splash10-014l-9000000000-ab534ce4a5c6314c7208 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 10V, Positive-QTOF | splash10-03dj-1960000000-8e1936b4490afdea1b45 | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 20V, Positive-QTOF | splash10-03di-3900000000-34acc3537097bf33c4ec | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 40V, Positive-QTOF | splash10-01ot-9400000000-9e7ebf6d4e248ffbf3bb | 2016-06-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 10V, Negative-QTOF | splash10-03di-2900000000-1aad1437a8d8217dea0e | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 20V, Negative-QTOF | splash10-03di-3900000000-0e379b4cf22b87e29955 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Ribavirin 40V, Negative-QTOF | splash10-0006-9100000000-0c0a02c5d745eb2131d7 | 2016-08-03 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|
General References | - Sidwell RW, Huffman JH, Khare GP, Allen LB, Witkowski JT, Robins RK: Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide. Science. 1972 Aug 25;177(4050):705-6. [PubMed:4340949 ]
- Sidwell RW, Bailey KW, Wong MH, Barnard DL, Smee DF: In vitro and in vivo influenza virus-inhibitory effects of viramidine. Antiviral Res. 2005 Oct;68(1):10-7. [PubMed:16087250 ]
- Bani-Sadr F, Carrat F, Pol S, Hor R, Rosenthal E, Goujard C, Morand P, Lunel-Fabiani F, Salmon-Ceron D, Piroth L, Pialoux G, Bentata M, Cacoub P, Perronne C: Risk factors for symptomatic mitochondrial toxicity in HIV/hepatitis C virus-coinfected patients during interferon plus ribavirin-based therapy. J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):47-52. [PubMed:16123681 ]
- Alvarez D, Dieterich DT, Brau N, Moorehead L, Ball L, Sulkowski MS: Zidovudine use but not weight-based ribavirin dosing impacts anaemia during HCV treatment in HIV-infected persons. J Viral Hepat. 2006 Oct;13(10):683-9. [PubMed:16970600 ]
|
---|